UKRI Fast HDX System direct award to Nicoya Lifesciences Inc

Tender information last checkedLast checked 14 Oct 2026, 12:21.

Opportunity overview

UKRI have selected a supplier to provide a millisecond-time-resolved HDX labelling system, including delivery and installation of the equipment.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Nicoya Lifesciences Inc

No match

Published award value: £282.5k
Awarded: 27 Sept 2026
Award ID: 1
Status: pending
Identifier: GB-PPON PWHH-4146-DTBY
Location: East Kitchener, CA, N2G 2K4, Canada

Classification

No classification was supplied.

Lots

Lot 1Value not stated

Documents and notices

Transparency notice on Find a TenderOpen source ↗

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id: UKRI-6277
Status: complete
Procurement Method: direct
Procurement Method Details: Direct award
Why this procedure was chosen: To meet the MRC Laboratory of Molecular Biology’s (LMB) multi-omics research objectives across proteomics, lipidomics, and metabolomics, the FastHDX platform incorporates several crucial, patented technologies: • Patented Flow & Delay-Loop Architecture: Rapid-mixing and multi-volume delay-loop switching system. Enables sub-second labelling down to millisecond timepoints while maintaining precise, software-controlled flow rates. • Back-Exchange Mitigation & Quench Control: Proprietary fluidic circuit with strict temperature control throughout the quench zone. Utilizes rapid online valve switching to transition sample directly into LC digestion columns without sample loss or back-exchange degradation. No other commercially available system meets the required technical specification to allow MRC LMB to meet their research objectives.

Legal basis

Id: 2023/54
Scheme: UKPGA
Uri: https://www.legislation.gov.uk/ukpga/2023/54/contents ↗

Procedure reasons

Entry 1

Id: singleSuppliersIntellectualPropertyExclusiveRights

Entry 2

Id: singleSuppliersTechnicalReasons

Lots and requirements

Entry 1

Id: 1
Status: complete

Suitability

Sme: Yes

Published documents

Entry 1

Id: conflictOfInterest
Document Type: conflictOfInterest
Description: Not published

Buyer, suppliers and contacts

Organisation 1

Name: UK Research & Innovation (UKRI)
Id: GB-PPON-PDQJ-7126-JDHG

Identifier

Scheme: GB-PPON
Id: PDQJ-7126-JDHG

Address

Street Address: Polaris House
Locality: Swindon, Wiltshire
Postal Code: SN2 1FL
Country: GB
Country Name: United Kingdom
Region: UKK14

Contact

Name: MRC Procurement
Email: mrcprocurement@ukri.org

Roles

buyer

Details

Url: https://www.ukri.org/ ↗

Classifications

Entry 1

Scheme: UK_CA_TYPE
Id: publicAuthorityCentralGovernment
Description: Public authority - central government

Organisation 2

Name: Nicoya Lifesciences Inc
Id: GB-PPON-PWHH-4146-DTBY

Identifier

Scheme: GB-PPON
Id: PWHH-4146-DTBY

Address

Street Address: B-29 King Street
Locality: East Kitchener
Postal Code: N2G 2K4
Country: CA
Country Name: Canada
Region: CA

Contact

Email: info@nicoyalife.com

Roles

supplier

Details

Scale: sme
Vcse: No

Award information

Award 1

Id: 1
Title: UKRI-6277 Fast HDX System
Status: pending
Main Procurement Category: goods
Above Threshold: Yes

Items

Item 1

Id: 1
Related Lot: 1

Additional Classifications

Entry 1

Scheme: CPV
Id: 38432000
Description: Analysis apparatus

Delivery locations

Entry 1

Region: UKH12
Country: GB
Country Name: United Kingdom

Value

Including VAT: 339,037.2
Amount: 282,531
Currency: GBP

Suppliers

Supplier 1

Id: GB-PPON-PWHH-4146-DTBY
Name: Nicoya Lifesciences Inc

Contract period

Starts: 28 Oct 2026, 00:00
Ends: 31 Mar 2027, 23:59

Related lots

Documents

Entry 1

Id: 096864-2026
Document Type: awardNotice
Notice Type: UK5
Description: Transparency notice on Find a Tender
Url: https://www.find-tender.service.gov.uk/Notice/096864-2026 ↗
Published: 14 Oct 2026, 10:55
Format: text/html

Milestones

Entry 1

Id: 1
Type: futureSignatureDate
Due: 26 Oct 2026, 23:59
Status: scheduled

Recorded locations

Buyer location · Swindon, Wiltshire · UKK14 · SN2 1FL · United Kingdom

Notice and amendment history

2 published notice versions reviewed by ProcuraAxis.

2 VERSIONS

096864-2026Transparency notice on Find a Tender · 14 Oct 2026, 10:55
096870-2026Contract award notice on Find a Tender · 14 Oct 2026, 10:59

PROCURAAXIS AWARD ANALYSIS

Award outcome intelligence

Evidence-bound analysis of the published award appears below the official tender and award information.

ANALYSIS PREVIEW

Award intelligence at a glance

UK Research & Innovation (UKRI) has issued a transparency notice for a direct award to Nicoya Lifesciences Inc for a millisecond-time-resolved HDX labelling system, including delivery and installation. The award remains pending; the published data does not evidence a signed or active contract.

Published outcome signals

Notice statusPublished transparency notice; procurement and lot marked completeEvidence: Process display status is awarded; source status is complete; notice type is “Transparency notice on Find a Tender”; lot 1 status is complete.
Award statusPendingEvidence: Award 1 status is “pending”.
Signature statusNot evidenced; future signature date scheduled for 26 October 2026Evidence: Award milestone type is futureSignatureDate, status scheduled, dueDate 2026-10-26T23:59:59Z.

97% approved-analysis confidence1 supplier record analysed3 source limitations

SOURCE AND FRESHNESS

Traceable procurement data

Source: Find a Tender
Notice reference: 096864-2026
OCID: ocds-h6vhtk-078738
First published: 14 Oct 2026
Last checked: 14 Oct 2026, 12:21
Notice versions reviewed: 2

View Find a Tender notice ↗

HOW THIS WAS PREPARED

Approved, evidence-bound analysis

ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.

Analysis status: Approved for publication
Analysed: 14 Oct 2026

Read the analysis methodology →

AWARD OUTCOME

What happened

Published outcome

Pending direct award to Nicoya Lifesciences Inc for award 1, covering lot 1.

Market significance

A £282,531 net goods award for specialist analytical equipment, justified by UKRI on patented technology and technical reasons.

AWARDED SUPPLIERS AND LOTS

1 supplier record analysed

Nicoya Lifesciences Inc

99% confidence

Award 1 · Lots 1 · £282,531 net; £339,037.20 gross GBP · Pending awardee

View supporting evidence

Award 1 names Nicoya Lifesciences Inc as supplier and reports amount £282,531 and amountGross £339,037.20; award status is pending.

LIFECYCLE

Award or contract stage

Notice status

95% confidence

Published transparency notice; procurement and lot marked complete

View supporting evidence

Process display status is awarded; source status is complete; notice type is “Transparency notice on Find a Tender”; lot 1 status is complete.

Award status

99% confidence

Pending

View supporting evidence

Award 1 status is “pending”.

Signature status

98% confidence

Not evidenced; future signature date scheduled for 26 October 2026

View supporting evidence

Award milestone type is futureSignatureDate, status scheduled, dueDate 2026-10-26T23:59:59Z.

VALUES

Published values explained

Award value (net)

99% confidence

£282,531

View supporting evidence

Award 1 value.amount is 282531 GBP.

Award value (gross)

99% confidence

£339,037.20

View supporting evidence

Award 1 value.amountGross is 339037.2 GBP.

Value allocation

97% confidence

The published award value applies to award 1, which covers the single listed lot; no separate lot value is published.

View supporting evidence

Award 1 relatedLots is [“1”]; lot 1 value is null.

TIMELINE

Procurement timeline

Award date

95% confidence

28 September 2026

View supporting evidence

Award record lists award_date 2026-09-28T00:00:00+01:00.

Transparency notice published

99% confidence

14 October 2026

View supporting evidence

Award notice document datePublished is 2026-10-14T10:55:32+01:00.

Scheduled signature date

98% confidence

26 October 2026

View supporting evidence

Future-signature milestone dueDate is 2026-10-26T23:59:59Z.

Published contract period

99% confidence

28 October 2026 to 31 March 2027

View supporting evidence

Award 1 contractPeriod startDate is 2026-10-28 and endDate is 2027-03-31.

SCOPE

What was awarded

Requirement

99% confidence

Millisecond-time-resolved HDX labelling system, including equipment delivery and installation.

View supporting evidence

Procurement title and description state this requirement.

Procurement category

99% confidence

Goods

View supporting evidence

Award 1 mainProcurementCategory is goods.

Classification

99% confidence

CPV 38432000 — Analysis apparatus

View supporting evidence

Award item additional classification is CPV 38432000, described as Analysis apparatus.

Delivery location

96% confidence

UKH12, United Kingdom

View supporting evidence

Award item deliveryAddresses lists region UKH12, GB.

PROCEDURE

Procedure and competition

Procedure

99% confidence

Direct award

View supporting evidence

Tender procurementMethod is direct and procurementMethodDetails is Direct award.

Published rationale

98% confidence

UKRI states that no other commercially available system meets the technical specification needed for MRC Laboratory of Molecular Biology research objectives.

View supporting evidence

Published procurementMethodRationale says the FastHDX platform has crucial patented technologies and that no other commercially available system meets the required specification.

Rationale classifications

99% confidence

Exclusive rights/intellectual property and technical reasons

View supporting evidence

procurementMethodRationaleClassifications lists singleSuppliersIntellectualPropertyExclusiveRights and singleSuppliersTechnicalReasons.

Competition information

99% confidence

No tender deadline, bidder count, evaluation scores or comparative pricing information is published.

View supporting evidence

Tender start and submission deadline are null; no bid, score or pricing-comparison fields are supplied.

CONTRACT TERMS

Published contract terms

Published term

99% confidence

28 October 2026 to 31 March 2027

View supporting evidence

Award 1 contractPeriod provides these dates.

Delivery and installation

99% confidence

Included in the stated requirement.

View supporting evidence

Procurement description specifies delivery and installation of the equipment.

Extension or renewal terms

99% confidence

Unknown

View supporting evidence

No extension or renewal provisions are supplied.

COMMERCIAL VIEW

Commercial observations

Market route

98% confidence

The opportunity was published as a direct award for a specialist analytical system rather than a competitive tender.

View supporting evidence

Procurement method is direct; rationale cites patented technologies and technical reasons.

Commercial maturity

99% confidence

The award is not yet evidenced as concluded because its status is pending and signature is scheduled in the future.

View supporting evidence

Award status is pending; futureSignatureDate milestone is scheduled for 26 October 2026.

ANALYSIS QUALITY

97%overall confidence

Confidence reflects the completeness and consistency of the published award data.

Reference: ocds-h6vhtk-078738
Analysed: 14 Oct 2026

APPROVED AWARD ANALYSIS

BUYER CONTEXT

Buyer context

Buyer

99% confidence

UK Research & Innovation (UKRI)

View supporting evidence

Buyer party is named UK Research & Innovation (UKRI).

Buyer type

99% confidence

Public authority — central government

View supporting evidence

Buyer details classification is publicAuthorityCentralGovernment.

Research context

97% confidence

MRC Laboratory of Molecular Biology multi-omics research objectives across proteomics, lipidomics and metabolomics.

View supporting evidence

Published direct-award rationale states this context.

SUPPLIER CONTEXT

Supplier context

Supplier

99% confidence

Nicoya Lifesciences Inc

View supporting evidence

Supplier party and award supplier both name Nicoya Lifesciences Inc.

Supplier location

95% confidence

East Kitchener, Canada

View supporting evidence

Supplier address lists locality East Kitchener and country Canada.

Supplier classification

98% confidence

SME

View supporting evidence

Supplier details lists scale as sme.

Identity verification context

99% confidence

Not applicable to the supplied Companies House verification workflow.

View supporting evidence

supplier_identity_status and supplierVerification status are not_applicable.

RENEWAL OUTLOOK

Renewal outlook

Estimated end-point

99% confidence

31 March 2027

View supporting evidence

Published contract period ends 2027-03-31.

Renewal outlook

98% confidence

No renewal option is published; the end date is an estimate of the current term endpoint, not a procurement forecast.

View supporting evidence

No renewal or extension terms are supplied; award contractPeriod ends 2027-03-31.

DATA QUALITY

Gaps and source limitations

Pending award and scheduled signature

99% confidence

The record is an award-stage transparency notice. It does not establish that a contract has been signed, started or is active.

View supporting evidence

Award status is pending and the signature milestone is scheduled.

Unpublished lot detail

99% confidence

Lot 1 has no published title, description or standalone value.

View supporting evidence

Lot 1 title, description and value fields are null.

Information not supplied in the published notice

99% confidence

Bid counts, evaluation results, pricing breakdown, tender deadline, extension provisions and renewal provisions are not supplied.

View supporting evidence

Relevant fields are absent or null in the supplied data.

SOURCE DATA LIMITATIONS

Information not supplied in the published notice

The award is pending, with a future signature milestone; no signed or active contract should be inferred.
Lot 1 has no published title, description or individual value.
Information not supplied in the published notice includes bid counts, evaluation details, pricing breakdown, tender deadline, and extension or renewal terms.

MARKET THEMES

Relevant award themes

COMMON QUESTIONS

About this award

Who is the proposed supplier for the UKRI Fast HDX System?

Nicoya Lifesciences Inc is named as the supplier for pending award 1.

What is the published award value?

The published value is £282,531 net and £339,037.20 gross.

Has the contract been signed?

The supplied notice does not evidence signature. The award is pending and lists a scheduled signature date of 26 October 2026.

Why was a direct award used?

UKRI cites patented technology, technical reasons and its view that no other commercially available system meets the required specification.

ProcuraAxis award analysis supplements, but does not replace, the official award notice, contract data or procurement documents. “Awarded” does not by itself prove that a contract has been signed.

UKRI-6277 Fast HDX System

Opportunity overview

Awarded to

Nicoya Lifesciences Inc

Classification

Lots

Documents and notices

Published notice details

Scope, procedure and submissions

Legal basis

Procedure reasons

Lots and requirements

Suitability

Published documents

Buyer, suppliers and contacts

Identifier

Address

Contact

Roles

Details

Classifications

Identifier

Address

Contact

Roles

Details

Award information

Items

Additional Classifications

Delivery locations

Value

Suppliers

Contract period

Related lots

Documents

Milestones

Recorded locations

Notice and amendment history

Award intelligence at a glance

Published outcome signals

Traceable procurement data

Approved, evidence-bound analysis

Continue your research